Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2024-03-01
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specifically, the implementation of an individualised treatment programme for palliative care patients will be carried out.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Patients who receive the treatment program, will previously constitute their own control group (waiting list control group).
No interventions assigned to this group
Experimental group
The study will commence with an initial evaluation (T1) one week after the patients' admission to the hospital. After an equal amount of time has passed without receiving any treatment, patients will undergo a re-evaluation (T2). Subsequently, patients will receive the music therapy treatment protocol, which consists of three sessions. Finally, patients will undergo a third evaluation (T3) after completing the treatment. Patients will undergo assessment before and after each music therapy session. Before the session, they will report their physical and emotional state, as well as their memory of the previous session's effects. After the session, they will be evaluated on their physical and emotional state, as well as the perceived effects of the current session. The therapy will consist of three individual sessions.
MERAKI_PC
The three music therapy sessions focus on helping the patient to adjust to their situation. The aim is to provide emotional support and encourage communication between family members through music. In addition, the therapy will help the patient to appreciate their remaining abilities and encourage their involvement in the rehabilitation process. The second session focuses on living in the present through re-identification. The session aims to improve the symptoms associated with the illness by focusing on the present situation and encouraging expression.
The main aim of the final session, 'The Journey of Life - Leaving a Mark', is to recapitulate and provide support.
Songs are used during the session, taking into account musical preferences.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MERAKI_PC
The three music therapy sessions focus on helping the patient to adjust to their situation. The aim is to provide emotional support and encourage communication between family members through music. In addition, the therapy will help the patient to appreciate their remaining abilities and encourage their involvement in the rehabilitation process. The second session focuses on living in the present through re-identification. The session aims to improve the symptoms associated with the illness by focusing on the present situation and encouraging expression.
The main aim of the final session, 'The Journey of Life - Leaving a Mark', is to recapitulate and provide support.
Songs are used during the session, taking into account musical preferences.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be over 18 years of age.
* Have preserved cognitive ability (SPMSQ, Pfeiffer). More than 2 errors (3 in illiterate persons) would suggest the presence of cognitive impairment.
* Have signed the informed consent form
* Have completed at least 2 of the 3 treatment sessions and have completed the pre-test and post-test assessment.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valencia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M. Antonia Pérez-Marín
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marián Pérez Marín, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Valencia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Dr. Moliner
Serra, Valencia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Miguel Fombuena, PhD
Role: primary
Selene Valero-Moreno, PhD
Role: backup
Isabel Bellver Vercher
Role: backup
Ana Alegre Soler
Role: backup
José Jorge Botella Trellis, Dr.
Role: backup
Cristina Rocío Espejo Fernández, Dra.
Role: backup
María Carmen Badía Picazo, Dra.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Meraki_Palliative Care
Identifier Type: -
Identifier Source: org_study_id